Latest News - Baxter
Top Corporates Hub
Baxter
How Investors May Respond To Baxter International (BAX) Expanding Into Automated IV Line Labeling Systems
04.04.2026 05:07
Baxter International has launched the IV Verify Line Labeling System in the U.S. after debuting it at the 2026 American Organization for Nursing Leadership Conference, offering an automated way to print standardized, color‑coded IV tubing labels that integrate barcodes, timing details, and patented ink‑free technology. The exclusive distribution agreement with Vigilant Software positions Baxter more firmly in medication safety automation, targeting persistent IV line labeling errors that can...
Leading Brands to Share ESG and Climate Strategies at Sustainability LIVE: The US Summit
30.03.2026 17:15
London, 30 March 2026 – BizClik and Sustainability Magazine has announced a distinguished lineup of Chief Sustainability Officers and sustainability leaders for Sustainability LIVE: The US Summit, taking place at Navy Pier, Chicago, on 21-22 April. The two-day event will bring together senior executives from some of the world's most recognised brands to address the evolving role of sustainability leadership in driving business transformation and measurable impact. Among the confirmed speakers ar
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings
30.03.2026 12:30
DEERFIELD, Ill., March 30, 2026--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter’s launch of the product is the result of a strategic and exclusive distribut
Clinical Nutrition for Cancer Care: 2026-2030 Market Analysis Featuring Profiles of Leading Players - Abbott Nutrition, Baxter International, B Braun Melsungen, Nestle Health Science, Danone Nutricia and More
27.03.2026 14:39
Clinical Nutrition for Cancer Care Market Clinical Nutrition for Cancer Care Market Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Clinical Nutrition for Cancer Care Market Report 2026" has been added to ResearchAndMarkets.com's offering. The clinical nutrition for cancer care market has experienced substantial growth, with the market size set to increase from $5.16 billion in 2025 to $5.42 billion in 2026, representing a compound annual growth rate (CAGR) of 5.1%. This upward trend is driven b
Bank of America Maintains a Hold Rating on Baxter International (BAX)
27.03.2026 07:24
Baxter International Inc. (NYSE:BAX) is one of the Best Mid Cap Value Stocks to Buy in 2026. On March 17, Travis Steed from Bank of America Securities maintained a Hold rating on Baxter International Inc. (NYSE:BAX) with a price target of $24. The rating comes after the S&P downgraded its outlook on the stock from […]
Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot
25.03.2026 13:00
Pet Partners, the nation's leading organization dedicated to improving human health and well-being through therapy animal interactions, and the Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced a new partnership to expand access to therapy animal programs in healthcare settings across the country. The initiative will begin as a two-year pilot program in key regions, including Northern California, Upstate New York and Greate
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks
25.03.2026 08:01
Oil prices have risen. Here's how Strait of Hormuz tensions could soon increase healthcare costs and make everyday medical supplies more expensive.
Baxter Announces CFO Transition
16.03.2026 12:45
DEERFIELD, Ill., March 16, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Joel Grade. Mr. Grade is leaving the company to prioritize family matters but will continue in an advisory capacity until April 30, 2026.
Baxter Intl Reaffirms FY2026 Adj EPS $1.85-$2.05 vs $2.25 Est; Sees Sales $11.244B-$11.356B vs $11.305B Est
16.03.2026 08:50
Baxter Intl (NYSE:BAX) is looking for FY2026 Adj EPS of $1.85-$2.05 vs $2.25 analyst estimate. sees sales of $11.244 billion-$11.356 billion vs $11.305 billion analyst estimate.
Baxter International CFO Joel Grade Departs, Effective April 30; Anita Zielinski Named Interim CFO, Effective Immediately
16.03.2026 08:46
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Joel Grade. Mr. Grade is leaving the company to prioritize family
Baxter Reshapes Portfolio With Kidney Spin Off And Margin Focus
07.03.2026 12:09
Baxter International (NYSE:BAX) is restructuring its business, including a spin-off of its kidney care unit. The company is realigning its portfolio to concentrate on higher margin medical products. These actions are intended to sharpen operational focus and reshape Baxter’s core business profile. Baxter sits at the intersection of hospital products, drug delivery and medical technologies, so any major reshuffle of its portfolio can affect how it competes across these categories. The...
Gapping S&P500 stocks in Friday's session
06.03.2026 15:35
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Friday to uncover the stocks that are gapping in the S&P500 index.
Baxter’s Ongoing Losses And Impairments Test The Investment Narrative
24.02.2026 11:07
Baxter International (NYSE:BAX) reported another substantial net loss for the recent quarter and full year. The company also recorded additional goodwill impairment charges tied to parts of its business. These items point to ongoing financial challenges and have raised fresh questions about Baxter's consistency and balance sheet strength. The pattern of repeated losses and impairments is material for shareholders assessing risk and stability. Baxter International, traded on the NYSE under...
Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading
20.02.2026 10:12
Key market opportunities in the fill finish manufacturing sector include rising demand for cell and gene therapies, expansion in personalized medicine production, and increased outsourcing to CMOs. Growth is driven by innovations in aseptic filling technologies, automated systems, and a focus on regulatory compliance. Fill Finish Manufacturing Market Fill Finish Manufacturing Market Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market Report 2026" has been added to Res
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment
16.02.2026 18:08
This global healthcare firm provides essential medical devices and therapies to hospitals and care facilities in over 100 countries.
Baxter’s New Decentralized Model Tests Earnings And Valuation Expectations
16.02.2026 17:12
Baxter International (NYSE:BAX) has announced a major organizational transformation with a new decentralized operating model. The company is also adjusting its board structure following mixed Q4 2025 results and ongoing operational challenges. The changes are part of a broader effort to address earnings underperformance, margin pressures, and efficiency efforts. Baxter International, a global medical products and therapies company, is reshaping how its business is run by pushing more...
Clinical Communication & Collaboration Market by Platform, Component, Application, End User - Global Forecast to 2030 with Cisco Systems, Oracle, Baxter, Avaya, Spok Leading
16.02.2026 15:41
The global clinical communication and collaboration market is set to reach $5.31 billion by 2030, growing at a CAGR of 13.02%. This growth is fueled by the increasing need for real-time communication, care coordination, and workflow efficiency in healthcare. A surge in mobile, cloud-based platform adoption and a shift to integrated, secure communication drives this expansion. Case studies from Stryker, Imprivata, and Ascom reveal notable improvements in staff responsiveness, patient admission ti
1 Mid-Cap Stock Worth Investigating and 2 We Brush Off
16.02.2026 04:37
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.